Metronidazole and Hepatocellular damage - a phase IV clinical study of FDA data

Summary:

Hepatocellular damage is reported as a side effect among people who take Metronidazole (metronidazole), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prilosec, and have High blood pressure.

The phase IV clinical study analyzes which people have Hepatocellular damage when taking Metronidazole. It is created by eHealthMe based on reports of 58,146 people who have side effects when taking Metronidazole from the FDA, and is updated regularly.

What is Metronidazole?

Metronidazole has active ingredients of metronidazole. It is often used in vaginitis bacterial. eHealthMe is studying from 59,578 Metronidazole users. Check the latest studies of Metronidazole.

What is Hepatocellular damage?

Hepatocellular damage (liver damage) is found to be associated with 508 drugs and 610 conditions by eHealthMe. Check the latest studies of Hepatocellular damage.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 20, 2026

58,146 people reported to have side effects when taking Metronidazole.
Among them, 30 people (0.05%) have Hepatocellular damage.

Could Metronidazole cause Hepatocellular damage?

Among these 30 people:

How long have people been on Metronidazole when they have Hepatocellular damage? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Hepatocellular damage when taking Metronidazole? *

  • female: 51.72 %
  • male: 48.28 %

What is the age of people who have Hepatocellular damage when taking Metronidazole? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 16.67 %
  • 30-39: 12.5 %
  • 40-49: 8.33 %
  • 50-59: 8.33 %
  • 60+: 54.17 %

What are other drugs people take besides Metronidazole? *

  1. Omeprazole: 5 people, 16.67%
  2. Prilosec: 5 people, 16.67%
  3. Prednisone: 4 people, 13.33%
  4. Crixivan: 3 people, 10.00%
  5. Ultram: 3 people, 10.00%
  6. Folic Acid: 3 people, 10.00%
  7. Fluconazole: 3 people, 10.00%
  8. Diflucan: 3 people, 10.00%
  9. Ibuprofen: 3 people, 10.00%
  10. Topiramate: 3 people, 10.00%

What are other side effects people have besides Hepatocellular damage? *

  1. Hepatic Failure (liver failure): 9 people, 30.00%
  2. Liver Function Tests Nos Abnormal: 6 people, 20.00%
  3. Fatigue (feeling of tiredness): 5 people, 16.67%
  4. Nausea (feeling of having an urge to vomit): 5 people, 16.67%
  5. Hepatitis Cholestatic (flow of bile from the liver is slowed or blocked): 5 people, 16.67%
  6. Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 5 people, 16.67%
  7. Fever: 4 people, 13.33%
  8. Blood Albumin Decreased: 4 people, 13.33%
  9. Hypotension (abnormally low blood pressure): 4 people, 13.33%
  10. Ascites (accumulation of fluid in the abdominal cavity): 4 people, 13.33%

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.67%
  2. High Blood Pressure: 2 people, 6.67%
  3. Mucosal Inflammation (infection of mucous membrane): 1 person, 3.33%
  4. Hypotension (abnormally low blood pressure): 1 person, 3.33%
  5. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 1 person, 3.33%
  6. Fever: 1 person, 3.33%
  7. Febrile Neutropenia (fever with reduced white blood cells): 1 person, 3.33%
  8. Constipation: 1 person, 3.33%
  9. Ascites (accumulation of fluid in the abdominal cavity): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Metronidazole and have Hepatocellular damage?

- Check whether Hepatocellular damage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Metronidazole:

Hepatocellular damage treatments and more:

How severe was Hepatocellular damage and when was it recovered:

Expand to all the drugs that have ingredients of metronidazole:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Metronidazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatocellular damage:

Browse all the conditions that are associated with Hepatocellular damage:


How the study uses the data?

The study uses data from the FDA. It is based on metronidazole (the active ingredients of Metronidazole) and Metronidazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: